Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PSNL
PERSONALIS, INC.
NASDAQ
$17.07
▲ UP 1.61% (0.27)

KEY STATISTICS

Market Cap$1.82 B
52w High$18.89
52w Low$4.67
Dividend Yield—
Frequency—
P/E-15.66
Volume2.97M
Shares Out.106.75M

COMPANY

LEADERSHIP

Christopher Hall
CHIEF EXECUTIVE
Christopher Hall

COMPENSATION 2026

Salary$618,000
Stock Awards$853,050
Incentive Plan Pay$247,200
All Other Comp.$3,000
Total$3,505,978

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 20, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
260

PRICE TARGET

Target High$17.00
Target Low$9.00
Target Median$16.25
Target Consensus$14.95

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$21.54M
NOV
3
TUE

PRICE

$17.07 ▲ UP 1.61% (+$0.27)
$16.80$17.00$17.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM17.07

About Personalis, Inc.

https://www.personalis.com ↗

Personalis, Inc. is a global cancer genomics company offering advanced sequencing, data analysis, and platforms like NeXT for tumor profiling, neoantigen prediction, and biomarker discovery to support cancer therapy development and research.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT PERSONALIS, INC. IS KNOWN FOR

NeXT Personal Dx
NeXT Personal Dx

NeXT Personal Dx is an ultra-sensitive whole-genome sequencing test that detects circulating tumor DNA for early cancer recurrence detection and personalized treatment monitoring.

COMPETITORS

COMPETITOR
ADPT COMPARE
GH COMPARE
NTRA COMPARE
TEM COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
107
LISTED HERE
14
RANKED BY POSITION SIZE
ARKG
5.64% · 7.2M
VTS.AX
0.00% · 2.1M
IWM
0.04% · 1.8M
DFAS
0.04% · 340.0K
R2US.L
0.04% · 131.2K
AVSC
0.05% · 100.2K
ETHO
0.78% · 88.9K
XRS2.DE
0.04% · 62.1K
GNOM
0.86% · 49.0K
FHLC
0.02% · 32.6K
PRFZ
0.02% · 32.1K
MRGR
2.94% · 27.4K
GINN
0.09% · 10.3K
USFMDN.MX
0.00% · 310

INSTITUTIONAL OWNERSHIP

SHARES OWNED
63.00%
HOLDERS
184
TOP 12 OF 184 · RANKED BY POSITION SIZE
Merck & Co., Inc.
14.0M sh · $111.8M
Lightspeed Management Company, L.L.C.
8.2M sh · $51.98M
Ark Investment Management LLC
7.9M sh · $50.6M
Ameriprise Financial Inc
7.6M sh · $48.37M
Blackrock, Inc.
5.6M sh · $36.8M
T. Rowe Price Investment Management, Inc.
4.8M sh · $30.31M
Aigh Capital Management LLC
3.9M sh · $25.38M
Abrdn Plc
3.5M sh · $22.22M
Blackrock Inc.
3.3M sh · $3.85M
Vanguard Group Inc
3.3M sh · $25.9M
Deep Track Capital, LP
3.0M sh · $19.11M
Kennedy Capital Management LLC
2.2M sh · $13.91M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Brian Mast
Brian Mast
Sale (Full)
2020-05-19

INSIDER TRADES

★
OFFICER: PRESIDENT AND CMO
Chen Richard
Sale · 100.0K shares
2026-07-15
★
OFFICER: PRESIDENT AND CMO
Chen Richard
Purchase · 100.0K shares
2026-07-15
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Hall Christopher M
Sale · 33.3K shares
2026-07-09
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Hall Christopher M
Sale · 66.7K shares
2026-07-09

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
HOLD 2
EQUAL WEIGHT 1
6 GRADES IN THE LAST 12 MONTHS
BTIG BUY Lake Street HOLD Needham HOLD Morgan Stanley EQUAL WEIGHT Guggenheim BUY HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CDNA$49.79COMPARE
BFLY$8.43COMPARE
TYRA$24.94COMPARE
MRVI$7.68COMPARE
CSTL$33.50COMPARE
GERN$1.51COMPARE
FLGT$19.61COMPARE
EVH$4.60COMPARE